Efalizumab and anorexia Patient Reports February 11, 2012

Efalizumab Side Effects Report #4789261-7
Efalizumab side effect was reported by a Physician from UNITED STATES on Sept 20, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, chronic sinusitis, diarrhoea, epstein-barr virus test positive, headache . Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4832046-3
Efalizumab side effect was reported by a Physician from UNITED STATES on Nov 08, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, antibody test positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood immunoglobulin g increased, chills, diarrhoea, eosinophil count increased. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4882701-4
Efalizumab side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bacteriuria, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood creatinine increased, candidiasis, chills. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4895651-4
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2006. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asymptomatic bacteriuria, blood alkaline phosphatase increased, candidiasis, culture urine positive, diarrhoea, enterococcal infection. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.


Efalizumab Side Effects Report #4691088-1
Efalizumab side effect was reported by a Physician from on May 27, 2005. Male patient, 57 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, fatigue, helicobacter gastritis, malaise, oesophageal candidiasis, vomiting, weight decreased. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient recovered.

Efalizumab Side Effects Report #5160389-5
Efalizumab side effect was reported by a Physician from UNITED STATES on Nov 06, 2006. Male patient, 55 years of age, weighting 245.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anorexia, chills, diverticulitis, encephalitis , headache , herpes virus infection, immune system disorder, meningitis viral, neck pain. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with ZOLOFT, ATENOLOL, METHOTREXATE, FOLIC ACID, METFORMIN, TRICOR, MIMYX CREAM, SALEX CREAM. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5129042-8
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, arthralgia, asthenia, calcinosis, condition aggravated, diverticulum intestinal, granuloma, haemangioma of liver. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5156994-2
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, arthralgia, asthenia, diverticulum intestinal, inflammation, joint swelling, lymphocyte percentage decreased, neutrophil percentage increased. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5179367-5
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, condition aggravated, diverticulum intestinal, haemangioma, inflammation, liver disorder, platelet count increased. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.